Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals

D'Haens, 2007, A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis, Gastroenterology, 132, 763, 10.1053/j.gastro.2006.12.038 Sandborn, 2002, A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease, Gastroenterology, 122, 512, 10.1053/gast.2002.31072 Levesque, 2015, Converging goals of treatment of inflammatory bowel disease from clinical trials and practice, Gastroenterology, 148, 37, 10.1053/j.gastro.2014.08.003 Black, 2013, Patient reported outcome measures could help transform healthcare, BMJ, 346, f167, 10.1136/bmj.f167 Weldring, 2013, Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs), Health Serv Insights, 6, 61 Khanna, 2015, A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity, Aliment Pharmacol Ther, 41, 77, 10.1111/apt.13001 Jairath, 2015, Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials, Aliment Pharmacol Ther, 42, 1200, 10.1111/apt.13408 Achleitner, 2012, Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures, J Crohns Colitis, 6, 507, 10.1016/j.crohns.2011.11.003 Williet, 2017, Patient-reported Outcomes in a French nationwide survey of inflammatory bowel disease patients, J Crohns Colitis, 11, 165, 10.1093/ecco-jcc/jjw145 IsHak, 2017, Patient-reported outcomes of quality of life, functioning, and GI/psychiatric symptom severity in patients with inflammatory bowel disease (IBD), Inflamm Bowel Dis, 23, 798, 10.1097/MIB.0000000000001060 Allen, 2013, Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease, Aliment Pharmacol Ther, 37, 438, 10.1111/apt.12187 Williet, 2014, Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease, Clin Gastroenterol Hepatol, 12, 1246, 10.1016/j.cgh.2014.02.016 Bojic, 2017, Patient reported outcome measures (PROMs) in inflammatory bowel disease: new data, J Crohns Colitis, 11, S576 Kim, 2018, Developing a standard set of patient-centred outcomes for inflammatory bowel disease: an international, cross-disciplinary consensus, J Crohns Colitis, 12, 408, 10.1093/ecco-jcc/jjx161 Ma, 2018, Heterogeneity in definitions of endpoints for clinical trials of ulcerative colitis: a systematic review for development of a core outcome set, Clin Gastroenterol Hepatol, 16, 637, 10.1016/j.cgh.2017.08.025 Janta, 2013, Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography, Rheumatology (Oxford), 52, 2243, 10.1093/rheumatology/ket297 Spiegel, 2014, Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales, Am J Gastroenterol, 109, 1804, 10.1038/ajg.2014.237 Schoepfer, 2014, Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis, Gastroenterology, 147, 1255, 10.1053/j.gastro.2014.08.028 Zittan, 2017, Development of the Harvey-Bradshaw Index-pro (HBI-PRO) score to assess endoscopic disease activity in Crohn's disease, J Crohns Colitis, 11, 543 Anderson, 2002, Using the empowerment approach to help patients change behavior, 3 2009, Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims, Federal Register, 74, 65132 Colombel, 2017, Management strategies to improve outcomes of patients with inflammatory bowel diseases, Gastroenterology, 152, 351, 10.1053/j.gastro.2016.09.046 de Jong, 2018, Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review, Clin Gastroenterol Hepatol, 16, 648, 10.1016/j.cgh.2017.10.019 De Vries, 2008, Using pooled kappa to summarize interrater agreement across many items, Field Methods, 20, 272, 10.1177/1525822X08317166 Bennebroek Evertsz, 2013, Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity, J Clin Gastroenterol, 47, 850, 10.1097/MCG.0b013e31828b2196 Bennebroek Evertsz, 2013, The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers, J Crohns Colitis, 7, 890, 10.1016/j.crohns.2012.11.007 Alexander, 2003, Patient-physician communication about out-of-pocket costs, JAMA, 290, 953, 10.1001/jama.290.7.953 Matthews, 2003, How true is true? Assessing socially desirable response bias, Qual Quant, 37, 327, 10.1023/A:1024420231961 Moshagen, 2010, Reducing socially desirable responses in epidemiologic surveys: an extension of the randomized-response technique, Epidemiology, 21, 379, 10.1097/EDE.0b013e3181d61dbc Jelsness-Jorgensen, 2017, Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue, United European Gastroenterol J, 5, 687, 10.1177/2050640616674654 Norton, 2017, Systematic review: interventions for abdominal pain management in inflammatory bowel disease, Aliment Pharmacol Ther, 46, 115, 10.1111/apt.14108 Sweeney, 2018, Systematic review: psychosocial factors associated with pain in inflammatory bowel disease, Aliment Pharmacol Ther, 47, 715, 10.1111/apt.14493 OECD (2013), OECD Guidelines on Measuring Subjective Well-being, OECD Publishing. http://dx.doi.org/10.1787/9789264191655-en. Tribbick, 2017, Differences across illness perceptions in inflammatory bowel disease and their relationships to psychological distress and quality of life, Gastroenterol Nurs, 40, 291, 10.1097/SGA.0000000000000225 Marin-Jimenez, 2016, Diagnostic performance of the Simple Clinical Colitis Activity Index self-administered online at home by patients with ulcerative colitis: CRONICA-UC Study, Am J Gastroenterol, 111, 261, 10.1038/ajg.2015.403 Van Deen, 2016, Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies, Clin Gastroenterol Hepatol, 14, 1742, 10.1016/j.cgh.2015.10.035 de Jong, 2017, Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial, Lancet, 390, 959, 10.1016/S0140-6736(17)31327-2 Rubin, 2009, Impact of ulcerative colitis from patients' and physicians' perspectives: results from the UC: NORMAL survey, Inflamm Bowel Dis, 15, 581, 10.1002/ibd.20793